Summary
This review, published in Nature Reviews Neurology, synthesises current evidence on the global and regional epidemiological burden of diabetic peripheral neuropathy (DPN), one of the most common and disabling complications of diabetes mellitus. Authored by a prominent international group of neuropathy researchers, it likely examines how DPN prevalence and impact differ across regions, with particular attention to under-resourced settings where diagnosis and management remain limited. The paper is expected to highlight the substantial and growing public health challenge posed by DPN in the context of rising global diabetes rates.
UK applicability
Whilst this is a global review, findings are directly relevant to the UK given the high and rising prevalence of type 2 diabetes within the NHS population and existing inequalities in diabetes complication rates across ethnic and socioeconomic groups. UK clinicians and public health policymakers may draw on regional burden data to inform screening and care pathway prioritisation.
Key measures
Prevalence (%), incidence rates, disability-adjusted life years (DALYs) or comparable burden metrics, regional variation in neuropathy burden, risk factor associations
Outcomes reported
The paper likely reports on the global and regional prevalence, incidence, and disability burden of diabetic peripheral neuropathy, examining how this complication varies across world regions and populations. It probably also considers risk factors, diagnostic challenges, and disparities in disease burden between high- and low-income settings.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.